Search Results Search Sort by RelevanceMost Recent Case and Commentary Oct 2003 Confidentiality of Patient Records Requested by the Court, Commentary 1 Howard Zonana, MD Psychiatrists can take various steps to uphold patient confidentiality when faced with a court order to disclose a patient's medical records. Virtual Mentor. 2003;5(10):420-424. doi: 10.1001/virtualmentor.2003.5.10.ccas3-0310. Case and Commentary Oct 2003 Confidentiality of Patient Records Requested by the Court, Commentary 2 Jeffrey L. Metzner, MD Psychiatrists can take various steps to uphold patient confidentiality when faced with a court order to disclose a patient's medical records. Virtual Mentor. 2003;5(10):425-429. doi: 10.1001/virtualmentor.2003.5.10.ccas3-0310. Medicine and Society Jul 2024 How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities. AMA J Ethics. 2024;26(7):E562-571. doi: 10.1001/amajethics.2024.562. Policy Forum Jul 2024 How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice? Ellen L. Edens, MD, MPE, MA, Gabriela Garcia Vassallo, MD, and Robert Heimer, PhD Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD. AMA J Ethics. 2024;26(7):E551-561. doi: 10.1001/amajethics.2024.551. In the Literature Jul 2024 How Should Harm Reduction Strategies Differ for Adolescents and Adults? Brady J. Heward, MD, Amy M. Yule, MD, and Peter R. Jackson, MD Recent increases in adolescent mortality from overdose have outpaced increases in mortality in members of the general population. AMA J Ethics. 2024;26(7):E534-545. doi: 10.1001/amajethics.2024.534. Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512. History of Medicine Jul 2024 Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies Sterling Johnson, JD, MA and Kimberly L. Sue, MD, PhD Black and queer community-based harm reduction practices can help guide development and implementation of anti-overdose interventions. AMA J Ethics. 2024;26(7):E580-586. doi: 10.1001/amajethics.2024.580. Case and Commentary Jul 2024 When Are “Paraphernalia” Critical Medical Supplies? Adriane M. dela Cruz, MD, PhD, Donald Egan, MD, MPH, Sarah E. Baker, MD, MA, and John Z. Sadler, MD Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality. AMA J Ethics. 2024;26(7):E527-533. doi: 10.1001/amajethics.2024.527. Case and Commentary Oct 2002 Patient Confidentiality and Overriding Social Considerations Faith Lagay, PhD An ethical case examines the definition of physician-client privilege as it relates to pregnancy test results. Virtual Mentor. 2002;4(10):296-298. doi: 10.1001/virtualmentor.2002.4.10.hlaw1-0210. State of the Art and Science Jan 2001 Should Genetic Information Be Treated Separately? Faith Lagay, PhD Current policy does not give special protection to a patient's genetic information or family history, but relies on society to decide who has access to this information and when. Virtual Mentor. 2001;3(1):4-6. doi: 10.1001/virtualmentor.2001.3.1.gnth1-0101. Pagination First page « First Previous page ‹ Previous … Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Current page 25 Page 26 Page 27 Next page Next › Last page Last »
Case and Commentary Oct 2003 Confidentiality of Patient Records Requested by the Court, Commentary 1 Howard Zonana, MD Psychiatrists can take various steps to uphold patient confidentiality when faced with a court order to disclose a patient's medical records. Virtual Mentor. 2003;5(10):420-424. doi: 10.1001/virtualmentor.2003.5.10.ccas3-0310.
Case and Commentary Oct 2003 Confidentiality of Patient Records Requested by the Court, Commentary 2 Jeffrey L. Metzner, MD Psychiatrists can take various steps to uphold patient confidentiality when faced with a court order to disclose a patient's medical records. Virtual Mentor. 2003;5(10):425-429. doi: 10.1001/virtualmentor.2003.5.10.ccas3-0310.
Medicine and Society Jul 2024 How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities. AMA J Ethics. 2024;26(7):E562-571. doi: 10.1001/amajethics.2024.562.
Policy Forum Jul 2024 How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice? Ellen L. Edens, MD, MPE, MA, Gabriela Garcia Vassallo, MD, and Robert Heimer, PhD Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD. AMA J Ethics. 2024;26(7):E551-561. doi: 10.1001/amajethics.2024.551.
In the Literature Jul 2024 How Should Harm Reduction Strategies Differ for Adolescents and Adults? Brady J. Heward, MD, Amy M. Yule, MD, and Peter R. Jackson, MD Recent increases in adolescent mortality from overdose have outpaced increases in mortality in members of the general population. AMA J Ethics. 2024;26(7):E534-545. doi: 10.1001/amajethics.2024.534.
Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512.
History of Medicine Jul 2024 Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies Sterling Johnson, JD, MA and Kimberly L. Sue, MD, PhD Black and queer community-based harm reduction practices can help guide development and implementation of anti-overdose interventions. AMA J Ethics. 2024;26(7):E580-586. doi: 10.1001/amajethics.2024.580.
Case and Commentary Jul 2024 When Are “Paraphernalia” Critical Medical Supplies? Adriane M. dela Cruz, MD, PhD, Donald Egan, MD, MPH, Sarah E. Baker, MD, MA, and John Z. Sadler, MD Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality. AMA J Ethics. 2024;26(7):E527-533. doi: 10.1001/amajethics.2024.527.
Case and Commentary Oct 2002 Patient Confidentiality and Overriding Social Considerations Faith Lagay, PhD An ethical case examines the definition of physician-client privilege as it relates to pregnancy test results. Virtual Mentor. 2002;4(10):296-298. doi: 10.1001/virtualmentor.2002.4.10.hlaw1-0210.
State of the Art and Science Jan 2001 Should Genetic Information Be Treated Separately? Faith Lagay, PhD Current policy does not give special protection to a patient's genetic information or family history, but relies on society to decide who has access to this information and when. Virtual Mentor. 2001;3(1):4-6. doi: 10.1001/virtualmentor.2001.3.1.gnth1-0101.